Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 35,361 | 33,474 | 29,446 | 28,268 | 0 |
| Operating Income | -35,361 | -33,474 | -29,446 | -28,268 | N/A |
| Interest Expense | 852 | 848 | 892 | 914 | 0 |
| Other Income | 64 | -92 | -90 | 398 | 0 |
| Pre-tax Income | -36,149 | -34,414 | -30,428 | -28,784 | 0 |
| Net Income Continuous | -36,149 | -34,414 | -30,428 | -28,784 | N/A |
| Net Income | $-36,149 | $-34,414 | $-30,428 | $-28,784 | $N/A |
| EPS Basic Total Ops | 1.46 | -0.63 | -2.28 | -2.16 | N/A |
| EPS Basic Continuous Ops | 1.46 | -0.63 | -2.28 | -2.16 | N/A |
| EPS Diluted Total Ops | 1.46 | -0.63 | -2.28 | -2.16 | N/A |
| EPS Diluted Continuous Ops | 1.46 | -0.63 | -2.28 | -2.16 | N/A |
| EBITDA(a) | $-34,328 | $-32,625 | $-28,772 | $-27,607 | $N/A |